C00-D48
Conditions
Interventions
Group 1: Pediatric cancer survivors after cessation of inpatient medical treatment receiving WBV-training in addition to standard care during the first (week 1-12) and standard care during the second
1x/week supervised by exercise physiologists, 2x/week supervised by parents at home. Each training session lasts 30 minutes at the most (18-27 Hz, 2mm Amplitude peak-to-peak, 5-10 repetitions per 60-9
Sponsors
Deutsche Sporthochschule Köln, Institut für Kreislaufforschugn und Sportmedizin, Abteilung Molekulare und Zelluläre Sportmedizin
Eligibility
Sex/Gender
All
Age
6 Years to 21 Years
Inclusion criteria
Inclusion criteria: • Completion of inpatient care for pediatric cancer within the last five years • Medical treatment for pediatric cancer included chemotherapy • Age between 6 and 21 years • Medical clearance of the treating physician prior to study participation • Written informed consent from the legal guardian and a child-specific informed assent from the participant prior to study participant
Exclusion criteria
Exclusion criteria: • Other diseases that go along with peripheral neuropaty/neuromuscular disorders • Amputations or other strong functional impairments of the lower limb • Palliative care • Specific conditions that would prevent participation in WBV-training or testing (following the physician’s advice) • exclusion criteria according to the suggestions of the device manufacturer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional mobility (Timed-up-and-Go-Test): t0 (baseline), t1 (after 12 weeks), t2 (after 24 weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| • Balance (one-leg stand) • walking capacity (2-minute walk test) • walking speed (10-meter walk test) • functional mobility (Timed-Up-And-Go-Test) • symptoms of chemotherapy-induced peripheral neuropathy (ped mTNS) • ankle dorsiflexion range of motion (goniometer) • strength of knee extensors and ankle dorsiflexors (hand-held dynamometer) • physical activity (accelerometer Aktigraph) • muscle fatigue (NIRS) • Satisfaction with the training program (questionnaire/safety (documentation of adverse Events)/ attendance/ WBV-related side-effects/ adherence to the vibration protocol time of testing: t0 (baseline), t1 (after 12 weeks), t2 (after 24 weeks) | — |
Countries
Germany
Contacts
Public ContactVanessa Oschwald
Deutsche Sporthochschule Köln, Institut für Kreislaufforschung und Sportmedizin, Abteilung Molekulare und Zelluläre Sportmedizin
Outcome results
None listed